herunterladen
Expanded Access Investigational New Drug (IND) Application Protocol:
Use of Diphtheria Antitoxin (DAT) for Suspected Diphtheria Cases
IND Sponsor: Centers for Disease Control and Prevention (CDC)
Protocol CDC IRB # 4167
BB IND 11184
Version Number 7.0
September 21, 2016
This IND protocol for DAT from the CDC contains information intended to guide treating
physicians regarding the use of investigational DAT. This document, and the contents within the
document, should not be altered during reproduction without prior authorization from the
CDC.
